Abstract
It is largely unrecognised that the impacts of asthma are different in patients with severe disease compared with patients with mild to moderate disease. Severe asthma is associated with a significant health-related quality of life (HRQoL) burden due to excessive symptoms, frequent and life-threatening attacks, increased comorbidity burden, and high pharmacological treatment requirements. Interventions aimed at improving HRQoL need to be specifically tested in populations with severe asthma, including multicomponent interventions targeting the many clinical characteristics associated with the disease. It is necessary to have patient-reported outcome measures developed specifically for severe asthma. Public health messages recognising the significant burden of severe asthma on quality of life are needed.
Original language | English |
---|---|
Pages (from-to) | S28-S33 |
Journal | Medical Journal of Australia |
Volume | 209 |
Issue number | 7 |
DOIs |
|
Publication status | Published - Jul 2018 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine